Arch Neurol. 2009 Jul;66(7):821-8. doi: 10.1001/archneurol.2009.104.

Emerging therapies for relapsing multiple sclerosis.

Source

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA. cohenj@ccf.org

Abstract

Six agents are currently approved by regulatory agencies to treat relapsing multiple sclerosis. Although these agents are effective and generally safe, some patients have continued disease activity or adverse effects. A sizable number of new agents are under investigation currently. This article reviews emerging agents that have shown promise in phase 2 trials.

PMID:: 19597083; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

Emerging oral therapies in multiple sclerosis. [Curr Neurol Neurosci Rep. 2010]
Emerging oral therapies in multiple sclerosis.
Conway D, Cohen JA. Curr Neurol Neurosci Rep. 2010 Sep; 10(5):381-8.
Review Current evidence and therapeutic strategies for multiple sclerosis. [Semin Neurol. 2008]
Review Current evidence and therapeutic strategies for multiple sclerosis.
Wingerchuk DM. Semin Neurol. 2008 Feb; 28(1):56-68.
Review Disease-modifying agents for multiple sclerosis: recent advances and future prospects. [Drugs. 2008]
Review Disease-modifying agents for multiple sclerosis: recent advances and future prospects.
Menge T, Weber MS, Hemmer B, Kieseier BC, von Büdingen HC, Warnke C, Zamvil SS, Boster A, Khan O, Hartung HP, et al. Drugs. 2008; 68(17):2445-68.
First oral therapies for multiple sclerosis anticipated. [Nat Rev Drug Discov. 2009]
First oral therapies for multiple sclerosis anticipated.
Hughes B. Nat Rev Drug Discov. 2009 Nov; 8(11):831-3.
Review Multiple sclerosis therapy: an update on recently finished trials. [J Neurol. 2007]
Review Multiple sclerosis therapy: an update on recently finished trials.
Kleinschnitz C, Meuth SG, Stüve O, Kieseier B, Wiendl H. J Neurol. 2007 Nov; 254(11):1473-90. Epub 2007 Nov 15.

See reviews... See all...

Cited by 4 PubMed Central articles

Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction. [Exp Ther Med. 2011]
Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.
Kikuchi K, Kawahara KI, Uchikado H, Miyagi N, Kuramoto T, Miyagi T, Morimoto Y, Ito T, Tancharoen S, Miura N, et al. Exp Ther Med. 2011 Sep; 2(5):771-775. Epub 2011 Jun 7.
Management of optic neuritis. [Indian J Ophthalmol. 2011]
Management of optic neuritis.
Menon V, Saxena R, Misra R, Phuljhele S. Indian J Ophthalmol. 2011 Mar-Apr; 59(2):117-22.
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis. [Ther Adv Neurol Disord. 2010]
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Frohman EM, Cutter G, Remington G, Gao H, Rossman H, Weinstock-Guttman B, Durfee JE, Conger A, Carl E, Treadaway K, et al. Ther Adv Neurol Disord. 2010 Jan; 3(1):15-28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Emerging therapies for relapsing multiple sclerosis.
Emerging therapies for relapsing multiple sclerosis.
Arch Neurol. 2009 Jul ;66(7):821-8. doi: 10.1001/archneurol.2009.104.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Emerging therapies for relapsing multiple sclerosis.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information